Identifying ligands at orphan GPCRs: current status using structure‐based approaches

No abstract is available for this paper.

• Publication year

  2016

• Venue

  British Journal of Pharmacology

• Publication date

  2016-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/bph.13452PMID 26837045PMCID PMC5341249
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identifying ligands at orphan GPCRs: current status using structure‐based approaches

  2016cited by this paper
• Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine

  2015cited by this paper
• Molecular Docking Screening Using Agonist-Bound GPCR Structures: Probing the A2A Adenosine Receptor

  2015influential reference
• The Concise Guide to PHARMACOLOGY 2015/16: G protein‐coupled receptors

  2015cited by this paper
• Using constitutive activity to define appropriate high-throughput screening assays for orphan g protein-coupled receptors.

  2015cited by this paper
• Efficacy and safety of fasiglifam (TAK-875), a G protein-coupled receptor 40 agonist, in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double-blind, placebo-controlled, phase III trial

  2015cited by this paper
• Methodological advances: the unsung heroes of the GPCR structural revolution

  2015cited by this paper
• Target selection for FDA-approved medicines.

  2015cited by this paper
• G Protein-Coupled Receptors in Drug Discovery

  2015cited by this paper
• The Concise Guide to PHARMACOLOGY 2015/16: Enzymes

  2015cited by this paper
• PRESTO-TANGO: an open-source resource for interrogation of the druggable human GPCR-ome

  2015cited by this paper
• Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65

  2015cited by this paper
• Expression Atlas update—an integrated database of gene and protein expression in humans, animals and plants

  2015cited by this paper
• From G Protein-coupled Receptor Structure Resolution to Rational Drug Design*

  2015cited by this paper
• Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain

  2014cited by this paper
• Structure‐Based and Fragment‐Based GPCR Drug Discovery

  2014cited by this paper
• GPCR-targeting nanobodies: attractive research tools, diagnostics, and therapeutics.

  2014cited by this paper
• Computer-Aided Discovery of Aromatic l-α-Amino Acids as Agonists of the Orphan G Protein-Coupled Receptor GPR139

  2014influential reference
• Structure of a Class C GPCR Metabotropic Glutamate Receptor 1 Bound to an Allosteric Modulator

  2014cited by this paper
• Advances in GPCR modeling evaluated by the GPCR Dock 2013 assessment: meeting new challenges.

  2014cited by this paper
• Impact of Template Choice on Homology Model Efficiency in Virtual Screening

  2014cited by this paper
• Femtosecond crystallography of membrane proteins in the lipidic cubic phase

  2014cited by this paper
• Structure-based discovery of selective serotonin 5-HT(1B) receptor ligands.

  2014cited by this paper
• High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875

  2014cited by this paper
• Screening β-Arrestin Recruitment for the Identification of Natural Ligands for Orphan G-Protein–Coupled Receptors

  2013cited by this paper
• Discovery of a Novel Selective Kappa-Opioid Receptor Agonist Using Crystal Structure-Based Virtual Screening

  2013cited by this paper
• Application of Monte Carlo-based receptor ensemble docking to virtual screening for GPCR ligands.

  2013cited by this paper
• Combination of ligand- and structure-based methods in virtual screening.

  2013cited by this paper
• A Strategy Combining Differential Low‐Throughput Screening and Virtual Screening (DLS‐VS) Accelerating the Discovery of new Modulators for the Orphan GPR34 Receptor

  2013influential reference
• Muscarinic Receptors as Model Targets and Antitargets for Structure-Based Ligand Discovery

  2013cited by this paper
• GPR3 Stimulates Aβ Production via Interactions with APP and β-Arrestin2

  2013cited by this paper
• 5-HT1A receptor pharmacophores to screen for off-target activity of α1-adrenoceptor antagonists

  2013cited by this paper
• G protein-coupled receptor deorphanizations.

  2013cited by this paper
• Towards Improved Quality of GPCR Models by Usage of Multiple Templates and Profile-Profile Comparison

  2013cited by this paper
• Structure of the human glucagon class B G-protein-coupled receptor

  2013cited by this paper
• Molecular signatures of G-protein-coupled receptors

  2013influential reference
• GPR88 Reveals a Discrete Function of Primary Cilia as Selective Insulators of GPCR Cross-Talk

  2013cited by this paper
• Structure of the human smoothened receptor bound to an antitumour agent

  2013cited by this paper
• Constitutive μ-Opioid Receptor Activity Leads to Long-Term Endogenous Analgesia and Dependence

  2013cited by this paper
• Ligand-Optimized Homology Models of D1 and D2 Dopamine Receptors: Application for Virtual Screening

  2013cited by this paper
• Randomized, Double-Blind, Dose-Ranging Study of TAK-875, a Novel GPR40 Agonist, in Japanese Patients With Inadequately Controlled Type 2 Diabetes

  2013cited by this paper
• Are GPCRs Still a Source of New Targets?

  2013cited by this paper
• New concepts in pharmacological efficacy at 7TM receptors: IUPHAR Review 2

  2013cited by this paper
• International Union of Basic and Clinical Pharmacology. LXXXVIII. G Protein-Coupled Receptor List: Recommendations for New Pairings with Cognate Ligands

  2013influential reference
• From heptahelical bundle to hits from the Haystack: structure-based virtual screening for GPCR ligands.

  2013cited by this paper
• Structure of class B GPCR corticotropin-releasing factor receptor 1

  2013cited by this paper
• Structure-Based Ligand Discovery Targeting Orthosteric and Allosteric Pockets of Dopamine Receptors

  2013cited by this paper
• G-Protein Coupled Receptor 83 (GPR83) Signaling Determined by Constitutive and Zinc(II)-Induced Activity

  2013cited by this paper
• The fatty acid receptor FFA1/GPR40 a decade later: how much do we know?

  2013cited by this paper
• Emerging paradigms in GPCR allostery: implications for drug discovery

  2013cited by this paper
• The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands

  2013influential reference
• Conformation Guides Molecular Efficacy in Docking Screens of Activated β-2 Adrenergic G Protein Coupled Receptor

  2013cited by this paper
• Fusion partner toolchest for the stabilization and crystallization of G protein-coupled receptors.

  2012cited by this paper
• Patent watch

  2012cited by this paper
• Ligand-guided receptor optimization.

  2012influential reference
• Identification of Structural Motifs Critical for Epstein-Barr Virus-Induced Molecule 2 Function and Homology Modeling of the Ligand Docking Site

  2012cited by this paper
• Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking

  2012influential reference
• ALiBERO: Evolving a Team of Complementary Pocket Conformations Rather than a Single Leader

  2012influential reference
• Current Assessment of Docking into GPCR Crystal Structures and Homology Models: Successes, Challenges, and Guidelines

  2012cited by this paper
• Identification of Novel Adenosine A2A Receptor Antagonists by Virtual Screening

  2012cited by this paper
• TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial.

  2012cited by this paper
• Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors.

  2012cited by this paper
• Tools for GPCR drug discovery

  2012cited by this paper
• From the protein's perspective: the benefits and challenges of protein structure-based pharmacophore modeling

  2012cited by this paper
• Structure-based ligand discovery for the protein–protein interface of chemokine receptor CXCR4

  2012influential reference
• Methods of protein structure comparison.

  2012cited by this paper
• Design, synthesis, and biological activity of potent and orally available G protein-coupled receptor 40 agonists.

  2011cited by this paper
• Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment.

  2011influential reference
• Crystal Structure of the β2Adrenergic Receptor-Gs protein complex

  2011cited by this paper
• Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation

  2011cited by this paper
• Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands.

  2011cited by this paper
• In silico identification of new ligands for GPR17: a promising therapeutic target for neurodegenerative diseases

  2011influential reference
• Ligand Discovery from a Dopamine D3 Receptor Homology Model and Crystal Structure

  2011influential reference
• GPCR-SSFE: A comprehensive database of G-protein-coupled receptor template predictions and homology models

  2011cited by this paper
• Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.

  2011cited by this paper
• High Constitutive Activity Is an Intrinsic Feature of Ghrelin Receptor Protein

  2011cited by this paper
• Cell Adhesion Receptor GPR133 Couples to Gs Protein*

  2011cited by this paper
• Discovery and SAR of a Series of Agonists at Orphan G Protein-Coupled Receptor 139.

  2011cited by this paper
• Selective Orthosteric Free Fatty Acid Receptor 2 (FFA2) Agonists

  2011influential reference
• Identification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of β-arrestin-2 and activate Gα13.

  2010influential reference
• Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists.

  2010cited by this paper
• Altered Immune Response in Mice Deficient for the G Protein-coupled Receptor GPR34*

  2010influential reference
• Allostery at G Protein-Coupled Receptor Homo- and Heteromers: Uncharted Pharmacological Landscapes

  2010cited by this paper
• Luciferase Reporter Assay System for Deciphering GPCR Pathways

  2010cited by this paper
• Structure-Based Discovery of Novel Chemotypes for Adenosine A 2 A Receptor Antagonists

  2010cited by this paper
• GPCR 3D homology models for ligand screening: Lessons learned from blind predictions of adenosine A2a receptor complex

  2010cited by this paper
• Structure of a nanobody-stabilized active state of the β2 adrenoceptor

  2010cited by this paper
• The Orphan G Protein–Coupled Receptor 3 Modulates Amyloid-Beta Peptide Generation in Neurons

  2009cited by this paper
• Patent watch

  2009cited by this paper
• The flexible pocketome engine for structural chemogenomics.

  2009cited by this paper
• Structure-based discovery of β2-adrenergic receptor ligands

  2009cited by this paper
• Customizing G Protein-coupled receptor models for structure-based virtual screening.

  2009cited by this paper
• Crystallizing membrane proteins using lipidic mesophases

  2009cited by this paper
• Yeast assays for G protein-coupled receptors.

  2009cited by this paper
• Lipid G Protein-coupled Receptor Ligand Identification Using β-Arrestin PathHunter™ Assay

  2009influential reference
• Identification of Surrogate Agonists and Antagonists for Orphan G-Protein-Coupled Receptor GPR139

  2009cited by this paper
• Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008

  2009cited by this paper
• International Union of Pharmacology. LXXI. Free Fatty Acid Receptors FFA1, -2, and -3: Pharmacology and Pathophysiological Functions

  2008cited by this paper
• Elucidation of signaling and functional activities of an orphan GPCR, GPR81 Published, JLR Papers in Press, January 3, 2008.

  2008cited by this paper
• Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening.

  2008cited by this paper

• Orphan receptor GPR153 facilitates vascular damage responses by modulating cAMP levels, YAP/TAZ signaling, and NF-κB activation

  2025influential citation
• Orphan G protein-coupled receptor GPRC5B controls macrophage function by facilitating prostaglandin E receptor 2 signaling

  2025cites this paper
• Constitutive activity among orphan G protein-coupled receptors: Molecular mechanisms and pharmacological perspectives.

  2025cites this paper
• Turbocharging protein binding site prediction with geometric attention, inter-resolution transfer learning, and homology-based augmentation

  2024cites this paper
• Application of FRET- and BRET-based live-cell biosensors in deorphanization and ligand discovery studies on orphan G protein-coupled receptors.

  2024cites this paper
• Orphan GPCR GPRC5C Facilitates Angiotensin II-Induced Smooth Muscle Contraction

  2024cites this paper
• Orphan G protein-coupled receptors: the ongoing search for a home

  2024influential citation
• Decrypting orphan GPCR drug discovery via multitask learning

  2024cites this paper
• Orphan receptor GPR176 in hepatic stellate cells exerts a profibrotic role in chronic liver disease

  2024cites this paper
• Current development in sulfonamide derivatives to enable CNS-drug discovery.

  2024cites this paper
• Potential role of G protein‑coupled receptor 124 in cardiovascular and cerebrovascular disease (Review)

  2024cites this paper
• Boosting Convolutional Neural Networks' Protein Binding Site Prediction Capacity Using SE(3)-invariant transformers, Transfer Learning and Homology-based Augmentation

  2023cites this paper
• Redocking the PDB

  2023cites this paper
• Gpr75 knockout mice display age-dependent cone photoreceptor cell loss

  2023cites this paper
• Orphan G Protein-Coupled Receptor GPR37 as an Emerging Therapeutic Target.

  2023cites this paper
• Opportunities and challenges in drug discovery targeting the orphan receptor GPR12.

  2023cites this paper
• Profiling of basal and ligand-dependent GPCR activities by means of a polyvalent cell-based high-throughput platform

  2023cites this paper
• Inverse agonism of lysophospholipids with cationic head groups at Gi-coupled receptor GPR82.

  2023cites this paper
• Allosteric modulators of solute carrier function: a theoretical framework

  2023cites this paper
• GPR101 loss promotes insulin resistance and diet-induced obesity risk

  2023cites this paper
• Structure–activity relationship of GPR15L peptide analogues and investigation of their interaction with the GPR15 receptor

  2023influential citation
• Why Search for Alternative GPCR Agonists?

  2023cites this paper
• Structure-based Discovery of Conformationally Selective Inhibitors of the Serotonin Transporter

  2022cites this paper
• Mind the Gap—Deciphering GPCR Pharmacology Using 3D Pharmacophores and Artificial Intelligence

  2022influential citation
• Downregulation of GPR160 inhibits the progression of glioma through suppressing epithelial to mesenchymal transition (EMT) biomarkers

  2022cites this paper
• Melatonin Receptors: A Key Mediator in Animal Reproduction

  2022cites this paper
• Heterotrimeric G proteins regulate planarian regeneration and behavior

  2022cites this paper
• The Deductive Reasoning Strategy Enables Biomedical Breakthroughs.

  2021cites this paper
• pdCSM-GPCR: predicting potent GPCR ligands with graph-based signatures

  2021cites this paper
• G-protein-coupled receptor P2Y10 facilitates chemokine-induced CD4 T cell migration through autocrine/paracrine mediators

  2021cites this paper
• G protein-coupled receptor-effector macromolecular membrane assemblies (GEMMAs).

  2021cites this paper
• Protein-Small Molecule Interactions in Native Mass Spectrometry.

  2021cites this paper
• MSA-Regularized Protein Sequence Transformer toward Predicting Genome-Wide Chemical-Protein Interactions: Application to GPCRome Deorphanization

  2021cites this paper
• The Evolving Role of Structural Biology in Drug Discovery

  2020cites this paper
• Free Fatty Acid Receptors in Health and Disease.

  2020cites this paper
• GPCR targets in type 2 diabetes

  2020cites this paper
• Tackling the complexities of orphan GPCR ligand discovery with rationally assisted approaches

  2020cites this paper
• Orphan G Protein–Coupled Receptor GPRC5B Controls Smooth Muscle Contractility and Differentiation by Inhibiting Prostacyclin Receptor Signaling

  2020cites this paper
• Feature Selection in GPCR Classification Using BAT Algorithm

  2020cites this paper
• Adaptive evolution of GPR39 in diverse directions in vertebrates.

  2020cites this paper
• A deep learning framework for elucidating whole-genome chemical interaction space

  2020cites this paper
• Recent Updates on Free Fatty Acid Receptor 1 (GPR-40) Agonists for the Treatment of Type 2 Diabetes Mellitus.

  2020cites this paper
• Genome-wide Prediction of Small Molecule Binding to Remote Orphan Proteins Using Distilled Sequence Alignment Embedding

  2020cites this paper
• GPCRs as an emerging host‐directed therapeutic target against mycobacterial infection: From notion to reality

  2020cites this paper
• G-Protein-Coupled Receptors

  2020cites this paper
• Understanding Membrane Protein Drug Targets in Computational Perspective.

  2019cites this paper
• Constitutively active BRS3 is a genuinely orphan GPCR in placental mammals

  2019cites this paper
• Cell signaling dependence of rapid glucocorticoid-induced endocannabinoid synthesis in hypothalamic neuroendocrine cells

  2019cites this paper
• CXCL14 Inhibits Insulin Secretion Independently of CXCR4 or CXCR7 Receptor Activation or cAMP Inhibition.

  2019cites this paper
• Molecular pharmacology of metabotropic receptors targeted by neuropsychiatric drugs

  2019cites this paper
• Exploring G Protein-Coupled Receptors (GPCRs) Ligand Space via Cheminformatics Approaches: Impact on Rational Drug Design

  2018cites this paper
• The G protein‐coupled receptors deorphanization landscape

  2018cites this paper
• Machine learning-assisted discovery of GPCR bioactive ligands

  2018cites this paper
• A dynamic and screening-compatible nanoluciferase-based complementation assay enables profiling of individual GPCR–G protein interactions

  2018cites this paper
• Development and Application of Molecular Modeling Methods for Structure-Based Drug Discovery

  2018cites this paper
• Crystal structure of misoprostol bound to the labor inducer prostaglandin E2 receptor

  2018cites this paper
• Automated discovery of GPCR bioactive ligands.

  2018cites this paper
• Chemical space of Escherichia coli dihydrofolate reductase inhibitors: New approaches for discovering novel drugs for old bugs

  2018cites this paper
• Comparative analysis on features extraction strategies for GPCR classification

  2018cites this paper
• Melatonin receptors: molecular pharmacology and signalling in the context of system bias

  2018cites this paper
• Recent Advances in Structure-Based Drug Design Targeting Class A G Protein-Coupled Receptors Utilizing Crystal Structures and Computational Simulations.

  2018cites this paper
• Emerging Roles of G Protein-Coupled Receptors in Hepatocellular Carcinoma

  2018cites this paper
• Conducting Nanomaterial Sensor Using Natural Receptors.

  2018cites this paper
• Identifying Signalling Pathways Regulated by GPRC5B in β-Cells by CRISPR-Cas9-Mediated Genome Editing

  2018cites this paper
• Orphan neuropeptides and receptors: Novel therapeutic targets.

  2017cites this paper
• Activation of the Orphan G Protein–Coupled Receptor GPR27 by Surrogate Ligands Promotes β-Arrestin 2 Recruitment

  2017influential citation
• GPR88 is a critical regulator of feeding and body composition in mice

  2017cites this paper
• cCMP and cUMP Across the Tree of Life: From cCMP and cUMP Generators to cCMP- and cUMP-Regulated Cell Functions.

  2017cites this paper
• Strategies for G-protein coupled receptor deorphanization

  2017cites this paper
• Receptor structure-based discovery of non-metabolite agonists for the succinate receptor GPR91

  2017cites this paper
• The Current State of Peptide Drug Discovery: Back to the Future?

  2017cites this paper
• Investigating G protein-coupled receptor 35 signalling and its role in cardiovascular disease

  2017cites this paper
• Single-cell profiling reveals heterogeneity and functional patterning of GPCR expression in the vascular system

  2017cites this paper
• Toward the next step in G protein-coupled receptor research: a knowledge-driven analysis for the next potential targets in drug discovery

  2016cites this paper
• RETRACTED ARTICLE: Orphan receptor ligand discovery by pickpocketing pharmacological neighbors

  2016cites this paper
• Molecular pharmacology of G protein‐coupled receptors

  2016cites this paper
• Application of GPCR Structures for Modelling of Free Fatty Acid Receptors.

  2016cites this paper
• In silico design of novel probes for the atypical opioid receptor MRGPRX2

  2016cites this paper
• Identifying ligands at orphan GPCRs: current status using structure‐based approaches

  2016cites this paper
• Functional Insights Into Novel Regulators of Plasma Lipids

  year unknowncites this paper
• Universitet Receptor structure-based discovery of non-metabolite agonists for the succinate receptor GPR 91

  year unknowncites this paper